Natural Alternatives International, Inc. (NAII)

US — Consumer Defensive Sector
Peers: PLAG  BON  BEDU  MWYN  HCWC  MTEX  EDTK  WVVI  PETZ  AFRI 

Automate Your Wheel Strategy on NAII

With Tiblio's Option Bot, you can configure your own wheel strategy including NAII - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol NAII
  • Rev/Share 20.9964
  • Book/Share 11.0754
  • PB 0.2582
  • Debt/Equity 0.8627
  • CurrentRatio 2.0579
  • ROIC -0.065

 

  • MktCap 17665585.0
  • FreeCF/Share 0.3752
  • PFCF 7.621
  • PE -1.3016
  • Debt/Assets 0.355
  • DivYield 0
  • ROE -0.1784

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Zacks Initiates Coverage of NAII With Neutral Recommendation
NAII
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive

Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates CFFI as "Neutral." Explore how Natural Alternatives' expansion, innovation and prudent management balance growth potential with margin and execution challenges in a dynamic supplement market.

Read More
image for news Zacks Initiates Coverage of NAII With Neutral Recommendation
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results
NAII
Published: February 14, 2025 by: GlobeNewsWire
Sentiment: Neutral

CARLSBAD, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 per diluted share, on net sales of $34.1 million for the second quarter of fiscal year 2025 compared to a net loss of $3.1 million, or $0.52 per diluted share, in the second quarter of the prior fiscal year.

Read More
image for news Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results

About Natural Alternatives International, Inc. (NAII)

  • IPO Date 1993-10-28
  • Website https://www.nai-online.com
  • Industry Packaged Foods
  • CEO Mark A. LeDoux
  • Employees 296
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.